vs

Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and Nordson Corporation (NDSN). Click either name above to swap in a different company.

Nordson Corporation is the larger business by last-quarter revenue ($669.5M vs $422.8M, roughly 1.6× EDGEWELL PERSONAL CARE Co). Nordson Corporation runs the higher net margin — 19.9% vs -15.5%, a 35.5% gap on every dollar of revenue. On growth, Nordson Corporation posted the faster year-over-year revenue change (8.8% vs -11.6%). Nordson Corporation produced more free cash flow last quarter ($122.9M vs $-137.5M). Over the past eight quarters, Nordson Corporation's revenue compounded faster (1.4% CAGR vs -16.0%).

The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..

Nordson Corporation is an American multinational corporation that designs and manufactures dispensing equipment for consumer and industrial adhesives, sealants and coatings. The company also manufactures equipment used in the testing and inspection of electronic components, technology-based systems for curing and surface treatment processes as well as medical devices and component technologies.

EPC vs NDSN — Head-to-Head

Bigger by revenue
NDSN
NDSN
1.6× larger
NDSN
$669.5M
$422.8M
EPC
Growing faster (revenue YoY)
NDSN
NDSN
+20.4% gap
NDSN
8.8%
-11.6%
EPC
Higher net margin
NDSN
NDSN
35.5% more per $
NDSN
19.9%
-15.5%
EPC
More free cash flow
NDSN
NDSN
$260.4M more FCF
NDSN
$122.9M
$-137.5M
EPC
Faster 2-yr revenue CAGR
NDSN
NDSN
Annualised
NDSN
1.4%
-16.0%
EPC

Income Statement — Q1 FY2026 vs Q1 FY2027

Metric
EPC
EPC
NDSN
NDSN
Revenue
$422.8M
$669.5M
Net Profit
$-65.7M
$133.4M
Gross Margin
38.1%
54.7%
Operating Margin
-4.5%
24.9%
Net Margin
-15.5%
19.9%
Revenue YoY
-11.6%
8.8%
Net Profit YoY
-3028.6%
40.9%
EPS (diluted)
$-1.41
$2.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPC
EPC
NDSN
NDSN
Q4 26
$669.5M
Q4 25
$422.8M
$751.8M
Q3 25
$600.5M
$741.5M
Q2 25
$627.2M
$682.9M
Q1 25
$580.7M
$615.4M
Q4 24
$415.1M
$744.5M
Q3 24
$517.6M
$661.6M
Q2 24
$647.8M
$650.6M
Net Profit
EPC
EPC
NDSN
NDSN
Q4 26
$133.4M
Q4 25
$-65.7M
$151.6M
Q3 25
$-30.6M
$125.8M
Q2 25
$29.1M
$112.4M
Q1 25
$29.0M
$94.7M
Q4 24
$-2.1M
$122.2M
Q3 24
$8.8M
$117.3M
Q2 24
$49.0M
$118.2M
Gross Margin
EPC
EPC
NDSN
NDSN
Q4 26
54.7%
Q4 25
38.1%
56.3%
Q3 25
37.9%
54.8%
Q2 25
42.8%
54.7%
Q1 25
44.1%
54.6%
Q4 24
41.6%
54.1%
Q3 24
41.1%
55.8%
Q2 24
44.3%
56.2%
Operating Margin
EPC
EPC
NDSN
NDSN
Q4 26
24.9%
Q4 25
-4.5%
28.5%
Q3 25
-4.2%
25.3%
Q2 25
8.6%
24.7%
Q1 25
10.1%
22.9%
Q4 24
2.2%
24.0%
Q3 24
3.9%
25.3%
Q2 24
12.8%
25.9%
Net Margin
EPC
EPC
NDSN
NDSN
Q4 26
19.9%
Q4 25
-15.5%
20.2%
Q3 25
-5.1%
17.0%
Q2 25
4.6%
16.5%
Q1 25
5.0%
15.4%
Q4 24
-0.5%
16.4%
Q3 24
1.7%
17.7%
Q2 24
7.6%
18.2%
EPS (diluted)
EPC
EPC
NDSN
NDSN
Q4 26
$2.38
Q4 25
$-1.41
$2.67
Q3 25
$-0.65
$2.22
Q2 25
$0.62
$1.97
Q1 25
$0.60
$1.65
Q4 24
$-0.04
$2.12
Q3 24
$0.18
$2.04
Q2 24
$0.98
$2.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPC
EPC
NDSN
NDSN
Cash + ST InvestmentsLiquidity on hand
$120.4M
Total DebtLower is stronger
$1.5B
$1.9B
Stockholders' EquityBook value
$1.5B
$3.1B
Total Assets
$3.8B
Debt / EquityLower = less leverage
1.03×
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPC
EPC
NDSN
NDSN
Q4 26
$120.4M
Q4 25
$108.4M
Q3 25
$147.8M
Q2 25
$130.2M
Q1 25
$130.4M
Q4 24
$116.0M
Q3 24
$209.1M
$165.3M
Q2 24
$125.4M
Total Debt
EPC
EPC
NDSN
NDSN
Q4 26
$1.9B
Q4 25
$1.5B
$2.0B
Q3 25
$1.4B
$2.1B
Q2 25
$1.4B
$2.2B
Q1 25
$1.4B
$2.2B
Q4 24
$1.4B
$2.2B
Q3 24
$1.3B
$1.5B
Q2 24
$1.3B
$1.5B
Stockholders' Equity
EPC
EPC
NDSN
NDSN
Q4 26
$3.1B
Q4 25
$1.5B
$3.0B
Q3 25
$1.6B
$3.0B
Q2 25
$1.6B
$3.0B
Q1 25
$1.5B
$2.9B
Q4 24
$1.5B
$2.9B
Q3 24
$1.6B
$2.9B
Q2 24
$1.6B
$2.8B
Total Assets
EPC
EPC
NDSN
NDSN
Q4 26
Q4 25
$3.8B
$5.9B
Q3 25
$3.8B
$6.0B
Q2 25
$3.8B
$6.1B
Q1 25
$3.8B
$5.9B
Q4 24
$3.7B
$6.0B
Q3 24
$3.7B
$5.2B
Q2 24
$3.7B
$5.2B
Debt / Equity
EPC
EPC
NDSN
NDSN
Q4 26
0.62×
Q4 25
1.03×
0.66×
Q3 25
0.89×
0.71×
Q2 25
0.88×
0.74×
Q1 25
0.95×
0.75×
Q4 24
0.97×
0.75×
Q3 24
0.81×
0.52×
Q2 24
0.82×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPC
EPC
NDSN
NDSN
Operating Cash FlowLast quarter
$-125.9M
$140.4M
Free Cash FlowOCF − Capex
$-137.5M
$122.9M
FCF MarginFCF / Revenue
-32.5%
18.4%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
1.05×
TTM Free Cash FlowTrailing 4 quarters
$36.3M
$646.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPC
EPC
NDSN
NDSN
Q4 26
$140.4M
Q4 25
$-125.9M
$202.9M
Q3 25
$74.1M
$238.0M
Q2 25
$114.8M
$119.2M
Q1 25
$45.1M
$159.1M
Q4 24
$-115.6M
$96.4M
Q3 24
$-388.3M
$164.8M
Q2 24
$101.2M
$122.6M
Free Cash Flow
EPC
EPC
NDSN
NDSN
Q4 26
$122.9M
Q4 25
$-137.5M
$193.9M
Q3 25
$46.5M
$226.4M
Q2 25
$99.3M
$103.1M
Q1 25
$28.0M
$137.7M
Q4 24
$-132.4M
$75.8M
Q3 24
$-414.2M
$143.0M
Q2 24
$88.6M
$108.2M
FCF Margin
EPC
EPC
NDSN
NDSN
Q4 26
18.4%
Q4 25
-32.5%
25.8%
Q3 25
7.7%
30.5%
Q2 25
15.8%
15.1%
Q1 25
4.8%
22.4%
Q4 24
-31.9%
10.2%
Q3 24
-80.0%
21.6%
Q2 24
13.7%
16.6%
Capex Intensity
EPC
EPC
NDSN
NDSN
Q4 26
Q4 25
2.7%
1.2%
Q3 25
4.6%
1.6%
Q2 25
2.5%
2.3%
Q1 25
2.9%
3.5%
Q4 24
4.0%
2.8%
Q3 24
5.0%
3.3%
Q2 24
1.9%
2.2%
Cash Conversion
EPC
EPC
NDSN
NDSN
Q4 26
1.05×
Q4 25
1.34×
Q3 25
1.89×
Q2 25
3.95×
1.06×
Q1 25
1.56×
1.68×
Q4 24
0.79×
Q3 24
-44.13×
1.41×
Q2 24
2.07×
1.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EPC
EPC

Other$242.0M57%
Sunand Skin Care Segment$131.5M31%
Shavinggelsandcreams$32.3M8%
Wipes And Other Skin Care Products$17.0M4%

NDSN
NDSN

Industrial Precision Solutions$326.9M49%
Medical and Fluid Solutions$193.2M29%
Advanced Technology Solutions$149.4M22%

Related Comparisons